Direct home delivery of colorectal cancer screening kits
EXPérimentation d'Envoi Postal DIrect à Domicile du kiT de dépistage du Cancer Colorectal Sans Commande préalable [Trial of Direct Home Delivery of Colorectal Cancer Screening Kit Without Pre-ordering]
NA · University Hospital, Caen · NCT06032338
This study is testing if sending colorectal cancer screening kits directly to people aged 50-51 can help more of them get screened compared to the usual method.
Quick facts
| Phase | NA |
|---|---|
| Study type | Interventional |
| Enrollment | 64000 (estimated) |
| Ages | 50 Years to 74 Years |
| Sex | All |
| Sponsor | University Hospital, Caen (other) |
| Locations | 1 site (Tours) |
| Trial ID | NCT06032338 on ClinicalTrials.gov |
What this trial studies
This trial evaluates the impact of mailing fecal immunochemical tests (FIT) directly to individuals eligible for colorectal cancer screening in the Centre-Val de Loire region. Participants will be randomly assigned to either a control group that follows standard procedures or to experimental groups that receive the test via direct home delivery with varying levels of prior communication. The study aims to assess participation and colonoscopy rates among first-time invitees aged 50-51. Ancillary studies will explore the acceptability of this intervention among healthcare providers.
Who should consider this trial
Good fit: Ideal candidates are individuals aged 50 to 74 residing in the Centre-Val de Loire region who are eligible for colorectal cancer screening.
Not a fit: Patients with a personal or family history of colorectal cancer or adenomas, inflammatory bowel disease, or those who have had a colonoscopy in the past five years may not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could significantly increase participation rates in colorectal cancer screening, leading to earlier detection and improved patient outcomes.
How similar studies have performed: Other studies have shown that direct mailing of screening tests can improve participation rates, suggesting this approach may be effective.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * 50 to 74 years old * Resident of Centre Val de Loire French area * Eligible for CRC screening invitation within the biennal CRC-PBOSP during the inclusion period * Affiliated to the health insurance scheme Exclusion Criteria: * CRC screening exclusion criteria notified to CRCDC-CVL in a previous screening round (family or personal history of CRC/adenoma, inflammatory bowel disease) * Colonoscopy in the previous 5 years) Subjects refusing data transmission to research team will be excluded from statistical analyses.
Where this trial is running
Tours
- Crcdc-Cvl — Tours, France (RECRUITING)
Study contacts
- Study coordinator: Lydia GUITTET, MD,PhD
- Email: guittet-l@chu-caen.fr
- Phone: +33(0)231065781
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Colorectal Cancer, Screening, Participation